Your browser doesn't support javascript.
loading
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.
Purdue, Mark P; Dutta, Diptavo; Machiela, Mitchell J; Gorman, Bryan R; Winter, Timothy; Okuhara, Dayne; Cleland, Sara; Ferreiro-Iglesias, Aida; Scheet, Paul; Liu, Aoxing; Wu, Chao; Antwi, Samuel O; Larkin, James; Zequi, Stênio C; Sun, Maxine; Hikino, Keiko; Hajiran, Ali; Lawson, Keith A; Cárcano, Flavio; Blanchet, Odile; Shuch, Brian; Nepple, Kenneth G; Margue, Gaëlle; Sundi, Debasish; Diver, W Ryan; Folgueira, Maria A A K; van Bokhoven, Adrie; Neffa, Florencia; Brown, Kevin M; Hofmann, Jonathan N; Rhee, Jongeun; Yeager, Meredith; Cole, Nathan R; Hicks, Belynda D; Manning, Michelle R; Hutchinson, Amy A; Rothman, Nathaniel; Huang, Wen-Yi; Linehan, W Marston; Lori, Adriana; Ferragu, Matthieu; Zidane-Marinnes, Merzouka; Serrano, Sérgio V; Magnabosco, Wesley J; Vilas, Ana; Decia, Ricardo; Carusso, Florencia; Graham, Laura S; Anderson, Kyra; Bilen, Mehmet A.
Afiliação
  • Purdue MP; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. purduem@mail.nih.gov.
  • Dutta D; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Machiela MJ; Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Gorman BR; Booz Allen Hamilton Inc, McLean, VA, USA.
  • Winter T; Laboratory of Genetic Susceptibility, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Okuhara D; Booz Allen Hamilton Inc, McLean, VA, USA.
  • Cleland S; Booz Allen Hamilton Inc, McLean, VA, USA.
  • Ferreiro-Iglesias A; Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
  • Scheet P; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu A; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Wu C; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
  • Antwi SO; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Larkin J; Biosample Repository, Fox Chase Cancer Center-Temple Health, Philadelphia, PA, USA.
  • Zequi SC; Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, USA.
  • Sun M; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, UK.
  • Hikino K; Department of Urology, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Hajiran A; National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation INCIT-INOTE, São Paulo, Brazil.
  • Lawson KA; Latin American Renal Cancer Group, São Paulo, Brazil.
  • Cárcano F; Department of Surgery, Division of Urology, São Paulo Federal University, São Paulo, Brazil.
  • Blanchet O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shuch B; Laboratory for Pharmacogenomics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
  • Nepple KG; Department of Urology, Division of Urologic Oncology, West Virginia University Cancer Institute, Morgantown, WV, USA.
  • Margue G; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Sundi D; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil.
  • Diver WR; Biobank Resource Centre, CHU Angers, Angers, France.
  • Folgueira MAAK; Department of Urology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
  • van Bokhoven A; Department of Urology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
  • Neffa F; Department of Urology, CHU Bordeaux, Bordeaux, France.
  • Brown KM; Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Hofmann JN; Department of Population Science, American Cancer Society, Atlanta, GA, USA.
  • Rhee J; Departments of Radiology and Oncology, Comprehensive Center for Precision Oncology-C2PO, Centro de Investigação Translacional em Oncologia, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas, Faculdade de Medicina Universidade de São Paulo, São Paulo, Brazil.
  • Yeager M; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
  • Cole NR; Tumor Bank, Hospital Militar, Montevideo, Uruguay.
  • Hicks BD; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Manning MR; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Hutchinson AA; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Rothman N; Cancer Genomics Research Laboratory, Frederick National Laboratory, Rockville, MD, USA.
  • Huang WY; Cancer Genomics Research Laboratory, Frederick National Laboratory, Rockville, MD, USA.
  • Linehan WM; Cancer Genomics Research Laboratory, Frederick National Laboratory, Rockville, MD, USA.
  • Lori A; Cancer Genomics Research Laboratory, Frederick National Laboratory, Rockville, MD, USA.
  • Ferragu M; Cancer Genomics Research Laboratory, Frederick National Laboratory, Rockville, MD, USA.
  • Zidane-Marinnes M; Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Serrano SV; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Magnabosco WJ; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Vilas A; Department of Urology, CHU Angers, Angers, France.
  • Decia R; Department of Pathology, CHU Angers, Angers, France.
  • Carusso F; Department of Medical Oncology, Barretos Cancer Hospital, Barretos, Brazil.
  • Graham LS; Department of Urology, Barretos Cancer Hospital, Barretos, Brazil.
  • Bilen MA; Department of Pathology, Hospital Pasteur, Montevideo, Uruguay.
Nat Genet ; 56(5): 809-818, 2024 May.
Article em En | MEDLINE | ID: mdl-38671320
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Locos de Características Quantitativas / Estudo de Associação Genômica Ampla / Neoplasias Renais Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Predisposição Genética para Doença / Polimorfismo de Nucleotídeo Único / Locos de Características Quantitativas / Estudo de Associação Genômica Ampla / Neoplasias Renais Idioma: En Ano de publicação: 2024 Tipo de documento: Article